全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Yongzhong Du , Hong Yuan ...
来源:[J].Biomaterials(IF 7.604), 2015, Vol.57, pp.1-11Elsevier
摘要:Abstract(#br)Antibody-mediated targeting therapy has been successful in treating patients with cancers by improving the specificity and clinical efficacy. In this study, we developed a human epidermal growth factor receptor-2 (HER2) antibody-conjugated drug delivery system, using...
作者:Yongzhong Du , Hong Yuan ...
来源:[J].Journal of Nanoparticle Research(IF 2.175), 2015, Vol.17 (1), pp.1-13Springer
摘要:Abstract(#br)Nanosized lipid carriers (NLC) can improve the limited drug-loading (DL) capacity and drug expulsion during storage, and adjust the drug release profile of solid lipid nanoparticles (SLN). In this study, Paclitaxel (PTX)-loaded NLC were prepared by solvent diffu...
作者:... Gaofeng Shu , Yongzhong Du , Xiaoying Ying
来源:[J].International Journal of Pharmaceutics(IF 3.458), 2020, Vol.576Elsevier
摘要:Abstract(#br)The conventional medications are still facing a huge challenge for the treatment of rheumatoid arthritis (RA). Thus, looking for an effective therapy of RA has became an urgent issue nowadays. In this study, a novel thermosensitive liposome loaded with sinomenin...
作者:Yongzhong Du , Qingpo Li ...
来源:[J].Nature Communications(IF 10.015), 2019, Vol.10 (1), pp.1-16DOAJ
摘要:Reactive oxygen species induced by endoplasmic reitculum stress can be exploited for cancer therapy. Here, nanoparticles are targetted to the endoplasmic reticulum and, when accompanied by PDT, produce stress resulting in calreticulin exposure on the cell surface, which activates...
作者:... Qingpo Li , Yongzhong Du , Jian You
来源:[J].Small(IF 7.823), 2017, Vol.13 (15), pp.n/a-n/aWiley
摘要:Endometriosis is difficult to treat since the side effects of the current therapeutic method and the high recurrence rate; thus, newer and safer therapeutic approaches are urgently needed. This work investigates the enhanced permeability and retention effect of CdTe quantum ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×